IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P. Form D/A filed July 21, 2026
View source on SEC EDGAR (opens in new tab)
- Disclosed offering amount
- Undisclosed
- Regulation D exemption
- 506(c)
- SEC accession number
- 0002071562-26-000003